Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (2): 185-187.DOI: 10.3969/j.issn.1673-8640.2018.02.019
• Orginal Article • Previous Articles Next Articles
Received:2017-03-29
Online:2018-02-28
Published:2018-03-02
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.02.019
| 项目 | 1月6日 | 1月8日 | 相对偏差（%） | 参考 区间 |
|---|---|---|---|---|
| 血浆空腹葡萄糖 （mmol/L） | 7.60 | 3.9~5.6 | ||
| 糖化血红蛋白 （%） | 8.40 | 4.0~6.0 | ||
| 尿蛋白（定性） | 阴性 | 阴性 | ||
| 尿糖（定性） | 阳性 | 阴性 | ||
| 尿量（L/24 h） | 1.30 | 1.20 | -7.69 | 无 |
| 尿总蛋白（g/L） | 0.19 | 1.25 | 557.89 | 无 |
| 尿白蛋白（mg/L） | 10.60 | 9.40 | -11.32 | 无 |
| 24 h尿总蛋白定量 （g/24 h） | 0.25 | 1.50 | 500.00 | 0~0.14 |
| 24 h尿白蛋白定量 （mg/24 h） | 13.80 | 11.30 | -18.11 | <30 |
| 项目 | 1月6日 | 1月8日 | 相对偏差（%） | 参考 区间 |
|---|---|---|---|---|
| 血浆空腹葡萄糖 （mmol/L） | 7.60 | 3.9~5.6 | ||
| 糖化血红蛋白 （%） | 8.40 | 4.0~6.0 | ||
| 尿蛋白（定性） | 阴性 | 阴性 | ||
| 尿糖（定性） | 阳性 | 阴性 | ||
| 尿量（L/24 h） | 1.30 | 1.20 | -7.69 | 无 |
| 尿总蛋白（g/L） | 0.19 | 1.25 | 557.89 | 无 |
| 尿白蛋白（mg/L） | 10.60 | 9.40 | -11.32 | 无 |
| 24 h尿总蛋白定量 （g/24 h） | 0.25 | 1.50 | 500.00 | 0~0.14 |
| 24 h尿白蛋白定量 （mg/24 h） | 13.80 | 11.30 | -18.11 | <30 |
| [1] | TOMIYASU T,HIRAHARA S,NOZAKI M,et al.Evaluation of diabetic retinopathy with ultra-wide field fluorescein angiography[J]. Nippon Ganka Gakkai Zasshi,2015,119(11):807-811. |
| [2] | IWATA J,NISHIKAZE O.New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine[J]. Clin Chem,1979,25(7):1317-1319. |
| [3] | HOHNADEL D C,KOLLER A.Method in Clinical Chemistry[M]. St. Louis:C. W. Mosby Co.,1987:35-45. |
| [4] | CHEUNG C K,MAK Y T,SWAMINATHAN R.Automated trichloroacetic acid precipitation method for urine total protein[J]. Ann Clin Biochem,1987,24(Pt 2):140-144. |
| [5] | TIETZ N W.Fundamentals of clinical chemistry[M]. 7th ed. Philadelphia,Pa:WB Saunders Co,2014:629. |
| [6] | LUXTON R W,PATEL P,KEIR G,et al.A micro-method for measuring total protein in cerebrospinal fluid by using benzethonium chloride in microtiter plate wells[J]. Clin Chem,1989,35(8):1731-1734. |
| [7] | BLOOM J N,HERMAN D C,ELIN R J,et al.Intravenous fluorescein interference with clinical laboratory tests[J]. Am J Ophthalmol,1989,108(4):375-379. |
| [8] | KOUMANTAKIS G,WYNDHAM L.Fluorescein interference with urinary creatinine and protein measurements[J]. Clin Chem,1991,37(10 Pt 1):1799. |
| [9] | O'GOSHI K,SERUP J. Safety of sodium fluorescein for in vivo study of skin[J]. Skin Res Technol,2006,12(3):155-161. |
| [10] | KROLL M H,ELIN R J.Interference with clinical laboratory analyses[J]. Clin Chem,1994,40(11 Pt 1):1996-2005. |
| [1] | FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114. |
| [2] | SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120. |
| [3] | LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129. |
| [4] | YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140. |
| [5] | XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146. |
| [6] | CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152. |
| [7] | . [J]. Laboratory Medicine, 2023, 38(12): 1153-1156. |
| [8] | . [J]. Laboratory Medicine, 2023, 38(12): 1157-1159. |
| [9] | WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166. |
| [10] | YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172. |
| [11] | DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176. |
| [12] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [13] | . [J]. Laboratory Medicine, 2023, 38(12): 1183-1185. |
| [14] | . [J]. Laboratory Medicine, 2023, 38(12): 1186-1190. |
| [15] | . [J]. Laboratory Medicine, 2023, 38(12): 1191-1194. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||
